High-salt-driven gut microbiota dysfunction aggravates prostatitis by promoting AHR/SGK1/FOXO1 axis-mediated Th17 cell differentiation
Jing Chen;Rui Feng;Bin-Bin Gong;Wei-Kang Wu;Bang-Shun Dai;Rui Tan;Wen-Long Xu;Tong Meng;Xiao-Bin Wang;Yun-Zheng Xiao;Cheng Yang;Li Zhang;Chao-Zhao Liang
High-salt-driven gut microbiota dysfunction aggravates prostatitis by promoting AHR/SGK1/FOXO1 axis-mediated Th17 cell differentiation
Jing Chen;Rui Feng;Bin-Bin Gong;Wei-Kang Wu;Bang-Shun Dai;Rui Tan;Wen-Long Xu;Tong Meng;Xiao-Bin Wang;Yun-Zheng Xiao;Cheng Yang;Li Zhang;Chao-Zhao Liang
Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease
Guo-Lin Miao;Wen-Xi Zhang;Yi-Tong Xu;Yi-Ran Liu;Ping-Ping Lai;Jia-Bao Guo;Gong-Lie Chen;Jing-Xuan Chen;Zi-Hao Zhou;Yan-Wei Li;Chong Zhang;Yang Ding;Lian-Xin Zhang;Yu-Fei Han;Jin-Xuan Chen;Jing-Dong Wu;Yin-Qi Zhao;Si Mei;Yang Zhao;Yuan-Wu Ma;Ling Zhang;Wei Huang;Dong-Yu Zhao;Er-Dan Dong;Yu-Hui Wang;Xun-De Xian
Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease
Guo-Lin Miao;Wen-Xi Zhang;Yi-Tong Xu;Yi-Ran Liu;Ping-Ping Lai;Jia-Bao Guo;Gong-Lie Chen;Jing-Xuan Chen;Zi-Hao Zhou;Yan-Wei Li;Chong Zhang;Yang Ding;Lian-Xin Zhang;Yu-Fei Han;Jin-Xuan Chen;Jing-Dong Wu;Yin-Qi Zhao;Si Mei;Yang Zhao;Yuan-Wu Ma;Ling Zhang;Wei Huang;Dong-Yu Zhao;Er-Dan Dong;Yu-Hui Wang;Xun-De Xian
Clinical-transcriptomic classification of lumbar disc degeneration enhanced by machine learning
Huai-Jian Jin;Peng Lin;Xiao-Yuan Ma;Sha Huang;Liang Zhang;Ou Hu;Yang-Yang Li;Ying-Bo Wang;Jun Zhu;Bo Hu;Jun-Gang Pu;Qin Qin;Pu-Lin Yan;Bing Liu;Yu Lan;Lin Chen;Yang-Li Xie;Jian He;Yi-Bo Gan;Peng Liu
Clinical-transcriptomic classification of lumbar disc degeneration enhanced by machine learning
Huai-Jian Jin;Peng Lin;Xiao-Yuan Ma;Sha Huang;Liang Zhang;Ou Hu;Yang-Yang Li;Ying-Bo Wang;Jun Zhu;Bo Hu;Jun-Gang Pu;Qin Qin;Pu-Lin Yan;Bing Liu;Yu Lan;Lin Chen;Yang-Li Xie;Jian He;Yi-Bo Gan;Peng Liu
推荐文章
更多- High-salt-driven gut microbiota dysfunction aggravates prostatitis by promoting AHR/SGK1/FOXO1 axis-mediated Th17 cell differentiation
- Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease
- Clinical-transcriptomic classification of lumbar disc degeneration enhanced by machine learning
快捷入口
作者投稿
编辑办公
- 最新文章
PERSPECTIVE
Glycosylation as a design component of biomaterials in implant design AI导读
摘要:An implanted medical device is specified in detail through its bulk and surface chemistry, mechanical properties, architecture, degradation kinetics, and surface ligands, whereas the host receiving it is specified hardly at all. Much of what the host presents at that interface is glycan, and glycan-mediated recognition acts through defined receptor families, including the Siglecs, the C-type lectin receptors, the galectins, and the regulators of complement. The host glycome is not fixed. It is assembled combinatorially, varies with age, metabolic state, and inflammation, differs between recipients, and is altered systematically in disease. Those alterations are measurable before implantation and are resolved both regionally and temporally, N-glycosylation differing region by region within the human Parkinsonian nigrostriatum and α-2,6-sialylation rising from 19.5% of the N-glycan pool in healthy intervertebral disc to 23%–24% in degenerated tissue. This Perspective argues that glycosylation should be specified as a component of the biomaterials from which devices are built. Because a diseased glycome is typically altered in several respects at once, a design need not address all of it, and a single motif may be selected where it is quantitatively dominant, mechanistically implicated, and chemically tractable. Three propositions follow: host glycophenotype is a measurable covariate of outcome and a basis for patient stratification; glycan structure, sulfation, and presentation density are specifiable material properties, with sulfation tunable independently of backbone; the analytical methods required to control a glycan attribute are established, so that the obstacle is convention rather than capability.<HTML><网络PDF><Meta-XML>25
15
0
COMMENTARY
EDITORIAL
RESEARCH
Infarct volume versus NIHSS score for ischemic and bleeding risk stratification after acute ischemic stroke AI导读
Zi-Mo Chen, Ying-Yu Jiang, Hong-Qiu Gu, Xin-Miao Zhang, Jing Jing, Jing-Lin Mo, Yong Jiang, Li-Ping Liu, Xing-Quan Zhao, Yong-Jun Wang, and Zi-Xiao Li
当前状态:一校优先2026 DOI: 10.1016/j.mmr.2026.100067摘要:Background:Whether infarct volume refines assessment of recurrent ischemic stroke (IS) and intracerebral hemorrhage (ICH) risk following acute IS beyond the National Institutes of Health Stroke Scale (NIHSS) remains uncertain. We compared their performance in ischemic-hemorrhagic risk stratification.Methods:We included 10,545 patients with acute IS from the Third China National Stroke Registry (CNSR-Ⅲ) with diffusion-weighted imaging/apparent diffusion coefficient-derived infarct volume and NIHSS data. Outcomes were 90-day recurrent IS and ICH, analyzed separately. Two reciprocal Cox models were used: one with infarct volume adjusted for NIHSS, and another with NIHSS adjusted for infarct volume. Stratified analyses, restricted cubic splines, and grouped threshold analyses were exploratory. In the GOLDEN BRIDGE Ⅱ study, recurrent IS and all bleeding events were assessed for external consistency.Results:In CNSR-Ⅲ, larger infarct volume was independently associated with recurrent IS [hazard ratio (HR)=1.35,95% confidence interval (CI) 1.25–1.47] and ICH (HR=2.48, 95% CI 2.11–2.91) after NIHSS adjustment, whereas NIHSS lost significance after infarct-volume adjustment (IS: HR=1.05, 95% CI 0.89–1.24; ICH: HR=1.11, 95% CI 0.78–1.58). ICH risk rose around 9.0 ml, with an increased hazard at 9.0–9.9 ml (HR=3.61, 95% CI 1.29–10.07), while IS risk increased without a sharp rise (HR=1.15, 95% CI 0.98–1.35). Patients with NIHSS score ≥4 and infarct volume <9.0 ml had IS risk comparable to NIHSS score ≤3 but potentially lower ICH risk (HR=0.63, 95% CI 0.38–1.02). Infarct volume 9.0–17.9 ml increased ICH risk (HR=1.96, 95% CI 1.06–3.63). Infarct volume was <9.0 ml in 66.7% of NIHSS score 6–15 and 25.4%of NIHSS score ≥16. GOLDEN BRIDGE Ⅱ confirmed principal findings, with infarct volume associated with recurrent IS(HR=1.37, 95% CI 1.25–1.49) and bleeding events (HR=1.53, 95% CI 1.31–1.78).Conclusions:Infarct volume better characterizes post-stroke ischemic-hemorrhagic risk than NIHSS. Prospective validation is required before using infarct volume to guide antiplatelet selection.<HTML><网络PDF><Meta-XML>20
16
0
RESEARCH
GastroAlert: a multimodal epigenetic blood test for early detection of gastric cancer using cell-free DNA AI导读
Yong-Jie Xu, Jian-Feng Xu, Chang-Fa Xia, Yu-Jie Wu, Dian-Ge Li, Tie-Yan Liu, Huai-Ping Cui, Jin Zhang, Liang Shang, Wan-Qing Chen
当前状态:一校优先2026 DOI: 10.1016/j.mmr.2026.100066摘要:Background:Gastric cancer remains a leading cause of cancer-related mortality worldwide, frequently diagnosed at advanced stages due to the limitations of current diagnostic approaches. While cell-free DNA (cfDNA)-based epigenetic profiling has emerged as a promising avenue for early cancer detection, comprehensive investigations into the epigenetic landscape of cfDNA in gastric cancer remain scarce. To address this gap, we aimed to develop and validate a multimodal epigenetic blood test for the non-invasive detection of gastric cancer.Methods:We developed GastroAlert, a multimodal epigenetic blood test that integrates cfDNA methylation, nucleosome footprinting, and fragmentation features into a single diagnostic approach for gastric cancer detection. A custom-designed capture probe panel was utilized to target gastric cancer-associated differentially methylated CpG sites and functionally relevant genes. Targeted enzymatic methylation sequencing was then performed on a discovery dataset consisting of 136 participants, including 53 gastric cancer patients, 55 individuals with benign gastric conditions, and 28 healthy controls. Subsequently, the diagnostic performance of GastroAlert was rigorously validated in an independent external dataset of 149 participants, comprising 79 gastric cancer cases and 70 non-cancer controls.Results:In cross-validation of the discovery dataset, GastroAlert achieved an area under the receiver operating characteristic curve (AUC) of 0.950 [95% confidence interval (CI) 0.874-0.995], with observed AUCs for conventional protein biomarkers ranging from 0.507 to 0.687. Notably, the locked GastroAlert model exhibited robust and reproducible performance in the independent validation dataset, yielding an AUC of 0.965 (95% CI 0.940-0.989) for distinguishing gastric cancer patients from non-cancer controls. For the clinically critical subset of early-stage gastric cancer cases, the model still maintained high diagnostic efficacy with an AUC of 0.921 (95% CI 0.862-0.980) in the discovery dataset and 0.948 (95% CI 0.910-0.985) in the validation dataset. Among all 79 gastric cancer cases in the validation dataset, the model attained an overall sensitivity of 0.898 (95% CI 0.813-0.948) at a specificity of 0.900 in the validation dataset.Conclusions:The findings demonstrate that multimodal epigenetic analysis of cfDNA provides a robust, non-invasive strategy for early gastric cancer detection, with potential clinical utility to improve patient outcomes.<HTML><网络PDF><Meta-XML>149
14
0
RESEARCH
Gadd45a knockout alleviates cisplatin-induced hearing loss by inhibiting CXCL family protein expression AI导读
Wei-Long Wang, Sheng-Yu Zou, Dan-Qi Wang, Yue Liu, Jia-Wen Li, Fang-Zi Ke, Si-Hui Wen, Bo-Wen Xu, Kun Lin, Chun-Jiang Wei, Xiao-Long Fu, Qiao-Jun Fang, Xiao-Xiang Xu, Xiong Chen, Zu-Hong He
当前状态:一校优先2026 DOI: 10.1016/j.mmr.2026.100063摘要:Background:Cisplatin is a widely used chemotherapeutic agent, but its clinical application is limited by serious ototoxic side effects, including hearing loss, tinnitus, and vertigo. Inflammation is now recognized as a significant contributor to cisplatin-induced hearing loss, but the upstream regulators remain largely undefined. This study aimed to identify novel regulators of cisplatin-induced ototoxicity through CRISPR-Cas9 screening and to determine the role of growth arrest and DNA damage-inducible alpha (GADD45A) in cochlear inflammation and hearing loss.Methods:To identify upstream regulators of cisplatin-induced ototoxicity, a CRISPR-Cas9-based loss-of-function screen was first performed in OC1 cells. Following the identification of Gadd45a as a candidate gene, its effects on cisplatin-induced cytotoxicity were evaluated using cell viability assays, flow cytometry, and TUNEL staining. Integrated transcriptomic and proteomic analyses were subsequently conducted to elucidate the downstream molecular mechanisms. Finally, the protective role of Gadd45a inhibition was validated in vivo through siRNA delivery into the posterior semicircular canal and in Gadd45a conditional knockout (cKO) mice.Results:Gadd45a knockout significantly inhibited cisplatin-induced cell death in the OC1 cell line while simultaneously enhancing autophagy signaling. Transcriptomic profiling revealed a marked downregulation of the expression of C-X-C motif chemokine ligand (CXCL) family cytokines following Gadd45a loss, which was further supported by proteomic analysis of culture supernatants. Mechanistically, Gadd45a knockout specifically inhibited nuclear factor κB subunit 1(NF-κB1) but not RELA proto-oncogene, NF-κB subunit (RELA). Immunofluorescence staining demonstrated that Gadd45a knockout inhibited the nuclear translocation of the NF-κB1 protein, and subsequent studies revealed that the NF-κB1 protein was degraded through the lysosomal pathway. In vivo, both si-Gadd45a injection into the semicircular canal and the knockout of Gadd45a effectively attenuated cisplatin-induced ototoxicity.Conclusions:This study identifies GADD45A as a key regulator of cisplatin ototoxicity and links the balance between apoptosis and autophagy with NF-κB1-CXCL-mediated inflammation. Targeted inhibition of GADD45A signaling may represent a promising therapeutic strategy to prevent hearing loss in patients receiving cisplatin chemotherapy.<HTML><网络PDF><Meta-XML>41
27
0
过刊浏览






RESEARCH
Minjin Jeong, Lucas G. Vattino, Maja Djurisic, Kevin P. Rose, Hiroshi Hyakusoku, Svetolik Spasic, Xiao-Jie Ma, Hiroaki Mohri, Ronna Hertzano, Anne E. Takesian, Konstantina M. Stankovic
2026, 13(9): 1377-1398. DOI: 10.1016/j.mmr.2026.100008关键词:Spiral ganglion neurons (SGNs);Human induced pluripotent stem cells (hiPSCs);Auditory neurons;cochlea;Inner ear<HTML><网络PDF><Meta-XML>58
70
0
RESEARCH
Chen-Ran Wang, Ren-Da Li, Pan Wang, Xue-Si Dong, Hao Zhang, Qing-Peng Zeng, Jia-Xin Xie, Zi-Lin Luo, Xiao-Lu Chen, Ya-Di Zheng, Ji-Bin Li, Yong-Jie Xu, Fei Wang, Ni Li, Feng-Wei Tan, Jie He
2026, 13(9): 1399-1416. DOI: 10.1016/j.mmr.2026.100020关键词:lung cancer;Screening eligibility;US Preventive Services Task Force (VSPSTF) criteria;Real-world evidence<HTML><网络PDF><Meta-XML>29
71
0
RESEARCH
Zi-Chao Li, Yi-Fu Zhu, Ya-Juan Song, Zhi-Jun Tan, Bin Liu, Yan Jiang, Hou-An Xiao, Dong-Mei Zu, Tong Wang, Yi Shi, Yan Jiao, Xue-Yong Li, Xing-Bo Xu, Lei Shang, Zhou Yu, Bao-Qiang Song
2026, 13(9): 1417-1440. DOI: 10.1016/j.mmr.2026.100021关键词:All-trans retinoic acid (ATRA);Randomized controlled trial (RCT);Glucose metabolic reprogramming;Myofibroblast activation;hypertrophic scar<HTML><网络PDF><Meta-XML>72
65
0
RESEARCH
Le-Yang Wu, Jia-Hui Qiu, Xin-Yue Qiao, Lin Li, Li-Yuan Qiao, Chen-Yang Li, Ying Sun, Shu-Hui Zhang, Zeng-Zheng Du, Xiao-Yao Chang, Cheng Cheng, Bo-Hao Wang, Yi-Han Xiao, Lin Lin, Zi-Chun Hua
2026, 13(9): 1441-1461. DOI: 10.1016/j.mmr.2026.100030关键词:Microbial therapeutics;Chemical biological modification;Quorum-sensing (QS);Tumor-targeted delivery;Immune activation<HTML><网络PDF><Meta-XML>51
55
0
RESEARCH
Shao-Yu Liu, Shao-Kang Xu, Jing-Li Gao, Xiao-Ke Kong, Jian Shi, Ya Miao, Yi-Ting Tang, Bin Zhao, Fang Fang, Ai-Tian Wang, Shou-Ling Wu, Jia-Qi Huang, Ben Lu
2026, 13(9): 1462-1478. DOI: 10.1016/j.mmr.2026.100031关键词:Metabolic syndrome (MetS);sepsis;Inflammation;Mortality;UK Biobank;Kailuan Study<HTML><网络PDF><Meta-XML>52
59
0
REVIEW
Noor Obaidi, Olivia Agee, Irene Yau, Robert Moritz, Kristo Nuutila
2026, 13(9): 1479-1492. DOI: 10.1016/j.mmr.2026.100007关键词:Cold weather injury;Frostbite;Field care of frostbite;Military medicine<HTML><网络PDF><Meta-XML>62
54
0
REVIEW
Yan-Hong Jiang, Xing-Juan Li, De-Cao Ma, Yong-Lin Chen, Yi-Yu Shi, Yang Lu, Ren-Fang Mao
2026, 13(9): 1493-1514. DOI: 10.1016/j.mmr.2026.100013关键词:sepsis;Endothelial dysfunction;Vascular permeability;Glycocalyx injury;Therapeutic strategies<HTML><网络PDF><Meta-XML>73
64
0
REVIEW
Zi-Jun Ma, Jun Chen, Chen-Xi Yang, Shun-Ping Lin, Quan Gong, Zachary Braunstein, Ying-Ying Wei, Xiao-Quan Rao, Ji-Xin Zhong
2026, 13(9): 1515-1542. DOI: 10.1016/j.mmr.2026.100015关键词:Autoimmune diseases (AIDs);pregnancy;Immune microenvironment;Maternal-fetal immune adaptation;Clinical management<HTML><网络PDF><Meta-XML>38
47
0
LETTER TO THE EDITOR
Li Li, Qi Han, Hao-Lei Bai, Qin Xiao, Xie He, Jia-Fei Chen, Zhi-Ming Zhen, Xue-Qin Luo, Yuan-Jing Zhang, Min-Min Lu, Xiao Wang, Shi-Yin Li, Jia-Xiang Xiong, Yun Wang, Zhi-An Hu, Xiao-Long Zhang, Yong Liu, Chao He
2026, 13(9): 1543-1546. DOI: 10.1016/j.mmr.2026.100035关键词:Neuropathic pain;Sleep disorders;Sleep fragmentation;Mediodorsal thalamus;Temporoparietal desynchronization<HTML><网络PDF><Meta-XML>55
42
0
COMMENTARY
关键词:Exosomes;Trace element;Diabetic foot ulcers;Stimuli-responsive hydrogel<HTML><网络PDF><Meta-XML>42
63
0
- 征稿通知
Informatics and Artificial Intelligence for Holistic Integrative Oncology
2025-07-03 16:51:41Cancer Biomarkers for Precision Oncology
2025-07-03 16:57:37New Biological Functional Materials for Trauma Medicine
2023-03-20 10:23:57Severe Torso Trauma
2023-03-20 10:40:50
- 推荐文章
- Informatics and Artificial Intelligence for Holistic Integrative Oncology
- New Biological Functional Materials for Trauma Medicine
- Microbiome
- COVID-19
- Diagnosis and treatment of heat stroke
- Tissue Engineering and Regenerative Medicine
- Severe Torso Trauma: Epidemiology, Diagnosis, Rescue and Management
- Sepsis and Septic Shock
- Post-Traumatic Stress Disorder (PTSD)
01
GastroAlert : a multimodal epigenetic blood test for early detection of gastric cancer using cell-free DNAYong-Jie Xu, Jian-Feng Xu, Chang-Fa Xia, Yu-Jie Wu, Dian-Ge Li, Tie-Yan Liu, Huai-Ping Cui, Jin Zhang, Liang Shang, Wan-Qing Chen
149
14
0
02The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050
Yu-Chang Zhou, Jiang-Mei Liu, Zhen-Ping Zhao, Mai-Geng Zhou, Marie Ng
135
128
0
03Strategies for promoting neurovascularization in bone regeneration
Xin-Ling Li, Yu-Qing Zhao, Li Miao, Yan-Xin An, Fan Wu, Jin-Yu Han, Jing-Yuan Han, Franklin R. Tay, Zhao Mu, Yang Jiao, Jing Wang
75
69
0
04Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study
Yun-Bo He, Jiao Hu, Zhi Liu, Zi-Cheng Xiao, Jin-Hui Liu, Hai-Su Liang, Wen-Zhi Deng, Zhi-Wei Li, Jun Zhang, Jia-Quan Long, Ning Gao, Bin Huang, Xi Guo, Zhen-Yu Ou, Jin-Bo Chen, Pei-Hua Liu, Min-Feng Chen, Hui-Huang Li, Rui-Zhe Wang, Xiao Guan, Shi-Yu Tong, Yang-Le Li, Wei He, Yan-Hua Zhao, Zhi-Yong Cai, Yu Gan, Cheng Zhao, Yu Cui, Yuan-Qing Dai, Yi Cai, Zhen-Yu Nie, Wei-Min Zhou, Bo-Han Zhou, Ming-Hui Hu, Ben-Yi Fan, Ding-Shan Deng, Xiong-Bing Zu
74
94
0
05ZBP1 activated by mitochondrial damage binds to STAT3 to suppress Legumain production and exacerbate macrophage inflammation in
Klebsiella pneumoniae -induced sepsisLi-Ting Deng, Huan Yang, Xu-Fei Zhang, Ze-Xing Lin, Ni Kuang, Hai-Yang Jiang, Pei-Zhao Liu, Yang-Guang Li, Xuan-Heng Li, Wei-Zhen Li, Chu-Jun Ni, Ming-Jie Qiu, Yue Chao, Yu-Fei Pan, Yi-Yu Yang, Ye-Ting Zhu, Yun Zhao, Jian-An Ren, Xiu-Wen Wu
70
17
0
01Investigation of the usefulness of zaleplon at two doses to induce afternoon-sleep under noise interference and its effects on psychomotor performance and vestibular function
48
626
0
02Biomaterials science and surface engineering strategies for dental peri-implantitis management
78
462
0
03Applications of CRISPR-Cas9 mediated genome engineering
30
258
0
04Undergraduate nursing education in the United States
10
251
0
05Oral administration of asparagine and 3-indolepropionic acid prolongs survival time of rats with traumatic colon injury
36
206
0

